Pinnacle Medicines | $89,000,000 | (Mar 27, 2026)
CurrentClient | $1,250,000 | (Mar 27, 2026)
Mirage | $75,000,000 | (Mar 27, 2026)
Certified by Founder
Lodge
Cervin
investor
United States
- Palo Alto, CA
- 16/11/2022
- Series A
- $14,000,000
Cervin is an early-stage venture capital firm primarily focused on the enterprise sector. The company’s partners actively work with early-stage founders and product visionaries to design, build and bring disruptive technologies to market in order to change how the world works.
- Industry Venture Capital and Private Equity Principals
- Website https://www.cervin.com/
- LinkedIn https://www.linkedin.com/company/cervin-ventures/
Scalvy | $13,900,000 | (Mar 27, 2026)
SIGMAS | $1,000,000 | (Mar 27, 2026)
VITL | $7,500,000 | (Mar 27, 2026)
Payy | $6,000,000 | (Mar 27, 2026)
Conntour | $7,000,000 | (Mar 27, 2026)
KilgourMD | Undisclosed Amount | (Mar 27, 2026)
Terrestrial | $50,000,000 | (Mar 27, 2026)
Krane | $9,000,000 | (Mar 26, 2026)
Zalos (YC F25) | $3,600,000 | (Mar 26, 2026)